Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-18 | New | $1,080,537 | $1,080,537 | Equity Only | 06c | SEC link |
| 2025-04-01 | New | $2,350,000 | $2,350,000 | Equity Only | 06c | SEC link |
| 2022-06-15 | New | $2,550,000 | $2,550,000 | Other | 06b | SEC link |
| 2021-09-02 | New | $6,950,000 | Unknown | Equity Only | SEC link | |
| 2021-07-06 | New | $1,025,000 | Unknown | Other | SEC link |
| Name | Role |
|---|---|
| Arunas Chesonis | Director, Executive, Promoter |
| Conor Cullinane | Director, Executive, Promoter |
| Matthew Kane | Director, Executive, Promoter |
| Elijah Kapas | Executive, Promoter |
| Parinaz Motamedy | Director |
| Joseph Nemmers | Director |